BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 37702419)

  • 1. Neurologic infections in people with HIV: shifting epidemiological and clinical patterns.
    Wan MM; Gill MJ; Fonseca K; Krentz H; Power C; Lang R
    AIDS; 2024 Jan; 38(1):49-58. PubMed ID: 37702419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association of HIV Control and Immunosuppression With Risk of Non-AIDS-Defining Cancer Risk Among Patients on Antiretroviral Therapy.
    Dickey BL; Yanik EL; Thompson Z; Burkholder G; Kitahata MM; Moore RD; Jacobson J; Mathews WC; Christopoulos KA; Fleming J; Napravnik S; Achenbach C; Coghill AE
    J Acquir Immune Defic Syndr; 2024 Mar; 95(3):275-282. PubMed ID: 37977197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors and Outcomes of Bloodstream Infections Among People With Human Immunodeficiency Virus: A Longitudinal Cohort Study From 2000 to 2017.
    Lang R; Gill MJ; Viczko J; Naugler C; Church D
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac318. PubMed ID: 35937645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral Breakthrough Episodes Among Persons with HIV in Care in Alberta, Canada: Clinical and Public Health Implications.
    Gill MJ; Lang R; Krentz HB
    AIDS Patient Care STDS; 2023 Jan; 37(1):1-10. PubMed ID: 36576421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Postvaccination Breakthrough COVID-19 Infections Among Adults With HIV in the United States.
    Coburn SB; Humes E; Lang R; Stewart C; Hogan BC; Gebo KA; Napravnik S; Edwards JK; Browne LE; Park LS; Justice AC; Gordon KS; Horberg MA; Certa JM; Watson E; Jefferson CR; Silverberg MJ; Skarbinski J; Leyden WA; Williams CF; Althoff KN;
    JAMA Netw Open; 2022 Jun; 5(6):e2215934. PubMed ID: 35671054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of Longitudinal Immune Dysfunction and Risk of AIDS and Non-AIDS Defining Malignancies in Antiretroviral-Treated People With Human Immunodeficiency Virus.
    Chammartin F; Mocroft A; Egle A; Zangerle R; Smith C; Mussini C; Wit F; Vehreschild JJ; d'Arminio Monforte A; Castagna A; Bailly L; Bogner J; de Wit S; Matulionyte R; Law M; Svedhem V; Tallada J; Garges HP; Marongiu A; Borges ÁH; Jaschinski N; Neesgaard B; Ryom L; Bucher HC;
    Clin Infect Dis; 2024 Apr; 78(4):995-1004. PubMed ID: 38092042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015.
    Sun J; Althoff KN; Jing Y; Horberg MA; Buchacz K; Gill MJ; Justice AC; Rabkin CS; Goedert JJ; Sigel K; Cachay E; Park L; Lim JK; Kim HN; Lo Re V; Moore R; Sterling T; Peters MG; Achenbach CJ; Silverberg M; Thorne JE; Mayor AM; Crane HM; Kitahata MM; Klein M; Kirk GD;
    JAMA Netw Open; 2021 Feb; 4(2):e2037512. PubMed ID: 33595662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of AIDS and non-AIDS related mortality among people living with HIV in Shiraz, southern Iran: a 20-year retrospective follow-up study.
    Gheibi Z; Shayan Z; Joulaei H; Fararouei M; Beheshti S; Shokoohi M
    BMC Infect Dis; 2019 Dec; 19(1):1094. PubMed ID: 31888541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early mortality in a cohort of people living with HIV in Rio de Janeiro, Brazil, 2004-2015: a persisting problem.
    Leite PHAC; Coelho LE; Cardoso SW; Moreira RI; Veloso VG; Grinsztejn B; Luz PM
    BMC Infect Dis; 2022 May; 22(1):475. PubMed ID: 35581552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of AIDS-defining events at initiation of antiretroviral therapy on long-term mortality of HIV/AIDS patients in Southwestern China: a retrospective cohort study.
    Huang Y; Zhou O; Zheng Z; Xu Y; Shao Y; Qin C; Qin F; Lai J; Liu H; Chen R; Ye L; Liang H; Qin X; Jiang J
    AIDS Res Ther; 2020 Jul; 17(1):44. PubMed ID: 32680536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AIDS and non-AIDS morbidity and mortality across the spectrum of CD4 cell counts in HIV-infected adults before starting antiretroviral therapy in Cote d'Ivoire.
    Anglaret X; Minga A; Gabillard D; Ouassa T; Messou E; Morris B; Traore M; Coulibaly A; Freedberg KA; Lewden C; Ménan H; Abo Y; Dakoury-Dogbo N; Toure S; Seyler C;
    Clin Infect Dis; 2012 Mar; 54(5):714-23. PubMed ID: 22173233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of factors influencing AIDS-related deaths among HIV-infected people in Shandong Province, 2017-2021].
    Zhao WY; Zhu XY; Li L; Zhang N; Huang PX; Liao MZ; Li YJ; Wang GY; Kang DM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2023 Oct; 44(10):1634-1640. PubMed ID: 37875453
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of antiretroviral therapy initiation time and baseline CD4
    Yang Y; Li Y; Zhang X; Zhang W; Ma Y; Jia X; Gondwe T; Wang Y; Shi X
    Glob Health Action; 2021 Jan; 14(1):1963527. PubMed ID: 34592916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4
    Vivancos-Gallego MJ; Okhai H; Perez-Elías MJ; Gomez-Ayerbe C; Moreno-Zamora A; Casado JL; Quereda C; Sanz JM; Sanchez-Conde M; Serrano-Villar S; Del Campo S; Dronda F; Galan JC; Sabin CA; Moreno S
    Antivir Ther; 2020; 25(2):91-100. PubMed ID: 32338638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of cotrimoxazole prophylaxis on
    Jiang J; Qin F; Meng S; Nehl EJ; Huang J; Liu Y; Zou J; Dong W; Huang J; Chen H; Zang N; Liang B; Ning C; Liao Y; Luo C; Liu H; Liu X; Wang J; Zhou O; Le T; Ye L; Wu F; Liang H
    Emerg Microbes Infect; 2019; 8(1):367-376. PubMed ID: 31851879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4/CD8 Ratio and CD4 Nadir Predict Mortality Following Noncommunicable Disease Diagnosis in Adults Living with HIV.
    Castilho JL; Turner M; Shepherd BE; Koethe JR; Furukawa SS; Bofill CE; Raffanti S; Sterling TR
    AIDS Res Hum Retroviruses; 2019 Oct; 35(10):960-967. PubMed ID: 31407605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival and risk factors associated with mortality in people living with HIV from 2005 to 2018 in Nanjing, China.
    Zhu Z; Xu Y; Wu S; Li X; Shi H; Dong X; Xu W
    Front Public Health; 2022; 10():989127. PubMed ID: 36339239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and outcomes of people living with HIV hospitalised at tertiary healthcare institutions during the COVID-19 pandemic in Mexico City.
    Caro-Vega Y; Guerrero-Torres L; Cárdenas-Ortega A; Martin-Onraët A; Rodríguez-Zulueta P; Romero-Mora K; Schjetnan MG; Piñeirúa-Menéndez A
    BMC Infect Dis; 2024 May; 24(1):524. PubMed ID: 38789972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
    Trickey A; May MT; Schommers P; Tate J; Ingle SM; Guest JL; Gill MJ; Zangerle R; Saag M; Reiss P; Monforte AD; Johnson M; Lima VD; Sterling TR; Cavassini M; Wittkop L; Costagliola D; Sterne JAC;
    Clin Infect Dis; 2017 Sep; 65(6):959-966. PubMed ID: 28903507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation.
    Chalouni M; Trickey A; Ingle SM; Sepuvelda MA; Gonzalez J; Rauch A; Crane HM; Gill MJ; Rebeiro PF; Rockstroh JK; Franco RA; Touloumi G; Neau D; Laguno M; Rappold M; Smit C; Sterne JAC; Wittkop L;
    AIDS; 2023 Aug; 37(10):1573-1581. PubMed ID: 37199601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.